Sfoglia per Rivista CANCER CHEMOTHERAPY AND PHARMACOLOGY
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer
2008-01-01 Fornaro, L.; Masi, G.; Bursi, S.; Loupakis, F.; Vasile, E.; Antonuzzo, A.; Chiara, S.; Pfanner, E.; DI PAOLO, Antonello; Bocci, Guido; DEL TACCA, M.; Falcone, Alfredo
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
2020-01-01 Cox, M. C.; Banchi, M.; Pelliccia, S.; Di Napoli, A.; Marcheselli, L.; Patti, C.; Anticoli Borza, P.; Battistini, R.; Di Gregorio, F.; Orlandi, P.; Bocci, G.
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia
2017-01-01 Galeotti, Laura; Ceccherini, Francesco; Domingo, Dario; Laurino, Marco; Polillo, Marialuisa; DI PAOLO, Antonello; Baratè, Claudia; Fava, Carmen; D'Avolio, Antonio; Cervetti, Giulia; Guerrini, Francesca; Fontanelli, Giulia; Ciabatti, Elena; Grassi, Susanna; Arrigoni, Elena; Danesi, Romano; Petrini, Mario; Cornolti, Fulvio; Saglio, Giuseppe; Galimberti, Sara
CARDIAC TOXICITY AND ANTITUMOR-ACTIVITY OF 4'-DEOXY-4'-IODO-DOXORUBICINOL
1990-01-01 Danesi, Romano; Marchetti, A; Bernardini, Nunzia; Larocca, Rv; Bevilacqua, Generoso; Deltacca, M.
Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines
2010-01-01 Nannizzi, S; Veal, Gj; Giovannetti, E; Mey, V; Ricciardi, S; Ottley, Cj; DEL TACCA, M; Danesi, Romano
Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate
1996-01-01 Innocenti, F; Danesi, Romano; DI PAOLO, Antonello; Loru, B; Favre, C; Nardi, Marco; Bocci, Guido; Nardini, D; Macchia, Pierantonio; DEL TACCA, M.
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone
2020-01-01 Crucitta, S.; Del Re, M.; Paolieri, F.; Bloise, F.; Sbrana, A.; Sammarco, E.; Mercinelli, C.; Cucchiara, F.; Fontanelli, L.; Galli, L.; Danesi, R.
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer
2009-01-01 Fornaro, L; Masi, G; Bursi, S; Loupakis, F; Vasile, E; Antonuzzo, A; Chiara, S; Pfanner, E; DI PAOLO, Antonello; Bocci, Guido; DEL TACCA, M; Falcone, Alfredo
The druggability of intracellular nucleotide-degrading enzymes
2016-01-01 Rampazzo, Chiara; Tozzi, MARIA GRAZIA; Dumontet, Charles; Jordheim, Lars Petter
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy
2019-01-01 Crucitta, S.; Restante, G.; Del Re, M.; Bertolini, I.; Bona, E.; Rofi, E.; Fontanelli, L.; Gianfilippo, G.; Fogli, S.; Stasi, I.; Ghilli, M.; Fontana, A.; Danesi, R.
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer
2010-01-01 Ferrandina, G; Mey, V; Nannizzi, S; Ricciardi, S; Petrillo, M; Ferlini, C; Danesi, Romano; Scambia, G; DEL TACCA, M.
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo
1999-01-01 Bocci, Guido; Danesi, Romano; Benelli, U.; Innocenti, F.; DI PAOLO, Antonello; Fogli, Stefano; Del Tacca, M.
Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation
2006-01-01 Allegrini, G; DI PAOLO, Antonello; Cerri, E; Cupini, S; Amatori, F; Masi, G; Danesi, Romano; Marcucci, L; Bocci, Guido; DEL TACCA, M; Falcone, Alfredo
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens
1999-01-01 Innocenti, F; Danesi, Romano; Bocci, Guido; Fogli, Stefano; DI PAOLO, Antonello; DEL TACCA, M.
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastroesophageal junction adenocarcinoma
2010-01-01 Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, Alfredo
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
2012-01-01 Petrini, Iacopo; Lencioni, M; Ricasoli, M; Iannopollo, M; Orlandini, C; Oliveri, F; Bartolozzi, Carlo; Ricci, S.
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
2018-01-01 Citi, Valentina; Del Re, Marzia; Martelli, Alma; Calderone, Vincenzo; Breschi, Maria Cristina; Danesi, Romano
Pro-apoptotic and cytostatic activity of naturally occurring cardenolides
2009-01-01 E., Bloise; Braca, Alessandra; N., DE TOMMASI; M. A., Belisario
Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats
1990-01-01 Danesi, Romano; Bernardini, Nunzia; Marchetti, A; Bernardini, M; DEL TACCA, M.
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
1999-01-01 Falcone, Alfredo; Allegrini, G.; Lencioni, M.; Pfanner, E.; Brunetti, I.; Cianci, C.; Galli, C.; Masi, G.; Antonuzzo, A.; Conte, P. F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer | 1-gen-2008 | Fornaro, L.; Masi, G.; Bursi, S.; Loupakis, F.; Vasile, E.; Antonuzzo, A.; Chiara, S.; Pfanner, E.; DI PAOLO, Antonello; Bocci, Guido; DEL TACCA, M.; Falcone, Alfredo | |
| All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma | 1-gen-2020 | Cox, M. C.; Banchi, M.; Pelliccia, S.; Di Napoli, A.; Marcheselli, L.; Patti, C.; Anticoli Borza, P.; Battistini, R.; Di Gregorio, F.; Orlandi, P.; Bocci, G. | |
| Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia | 1-gen-2017 | Galeotti, Laura; Ceccherini, Francesco; Domingo, Dario; Laurino, Marco; Polillo, Marialuisa; DI PAOLO, Antonello; Baratè, Claudia; Fava, Carmen; D'Avolio, Antonio; Cervetti, Giulia; Guerrini, Francesca; Fontanelli, Giulia; Ciabatti, Elena; Grassi, Susanna; Arrigoni, Elena; Danesi, Romano; Petrini, Mario; Cornolti, Fulvio; Saglio, Giuseppe; Galimberti, Sara | |
| CARDIAC TOXICITY AND ANTITUMOR-ACTIVITY OF 4'-DEOXY-4'-IODO-DOXORUBICINOL | 1-gen-1990 | Danesi, Romano; Marchetti, A; Bernardini, Nunzia; Larocca, Rv; Bevilacqua, Generoso; Deltacca, M. | |
| Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines | 1-gen-2010 | Nannizzi, S; Veal, Gj; Giovannetti, E; Mey, V; Ricciardi, S; Ottley, Cj; DEL TACCA, M; Danesi, Romano | |
| Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate | 1-gen-1996 | Innocenti, F; Danesi, Romano; DI PAOLO, Antonello; Loru, B; Favre, C; Nardi, Marco; Bocci, Guido; Nardini, D; Macchia, Pierantonio; DEL TACCA, M. | |
| CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone | 1-gen-2020 | Crucitta, S.; Del Re, M.; Paolieri, F.; Bloise, F.; Sbrana, A.; Sammarco, E.; Mercinelli, C.; Cucchiara, F.; Fontanelli, L.; Galli, L.; Danesi, R. | |
| A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer | 1-gen-2009 | Fornaro, L; Masi, G; Bursi, S; Loupakis, F; Vasile, E; Antonuzzo, A; Chiara, S; Pfanner, E; DI PAOLO, Antonello; Bocci, Guido; DEL TACCA, M; Falcone, Alfredo | |
| The druggability of intracellular nucleotide-degrading enzymes | 1-gen-2016 | Rampazzo, Chiara; Tozzi, MARIA GRAZIA; Dumontet, Charles; Jordheim, Lars Petter | |
| Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy | 1-gen-2019 | Crucitta, S.; Restante, G.; Del Re, M.; Bertolini, I.; Bona, E.; Rofi, E.; Fontanelli, L.; Gianfilippo, G.; Fogli, S.; Stasi, I.; Ghilli, M.; Fontana, A.; Danesi, R. | |
| Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer | 1-gen-2010 | Ferrandina, G; Mey, V; Nannizzi, S; Ricciardi, S; Petrillo, M; Ferlini, C; Danesi, Romano; Scambia, G; DEL TACCA, M. | |
| Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo | 1-gen-1999 | Bocci, Guido; Danesi, Romano; Benelli, U.; Innocenti, F.; DI PAOLO, Antonello; Fogli, Stefano; Del Tacca, M. | |
| Irinotecan in combination with thalidomide in patients with advanced solid tumors: a clinical study with pharmacodynamic and pharmacokinetic evaluation | 1-gen-2006 | Allegrini, G; DI PAOLO, Antonello; Cerri, E; Cupini, S; Amatori, F; Masi, G; Danesi, Romano; Marcucci, L; Bocci, Guido; DEL TACCA, M; Falcone, Alfredo | |
| Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens | 1-gen-1999 | Innocenti, F; Danesi, Romano; Bocci, Guido; Fogli, Stefano; DI PAOLO, Antonello; DEL TACCA, M. | |
| Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastroesophageal junction adenocarcinoma | 1-gen-2010 | Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, Alfredo | |
| Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma | 1-gen-2012 | Petrini, Iacopo; Lencioni, M; Ricasoli, M; Iannopollo, M; Orlandini, C; Oliveri, F; Bartolozzi, Carlo; Ricci, S. | |
| Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro | 1-gen-2018 | Citi, Valentina; Del Re, Marzia; Martelli, Alma; Calderone, Vincenzo; Breschi, Maria Cristina; Danesi, Romano | |
| Pro-apoptotic and cytostatic activity of naturally occurring cardenolides | 1-gen-2009 | E., Bloise; Braca, Alessandra; N., DE TOMMASI; M. A., Belisario | |
| Protective effects of fructose-1,6-diphosphate on acute and chronic doxorubicin cardiotoxicity in rats | 1-gen-1990 | Danesi, Romano; Bernardini, Nunzia; Marchetti, A; Bernardini, M; DEL TACCA, M. | |
| Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study | 1-gen-1999 | Falcone, Alfredo; Allegrini, G.; Lencioni, M.; Pfanner, E.; Brunetti, I.; Cianci, C.; Galli, C.; Masi, G.; Antonuzzo, A.; Conte, P. F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile